The Department of Radiation Oncology and our faculty are involved with numerous active clinical trials as sponsors and collaborators. Our current active studies are listed below. If you have any questions about the particular study, please contact the study coordinator.
Feinberg Clinical Trials
Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.
Clinical Research Office
Find more about the clinical research done within the Robert H. Lurie Comprehensive Cancer Center through the Clinical Research Office.
|Adam Prescott||Eric Donnelly, MD||Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery (NU UCSF14B02)|
|Adam Prescott||Eric Donnelly, MD||A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (RTOG 0920)|
|Adam Prescott||Eric Donnelly, MD||A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (Time-C) (RTOG 1203)|
|Adam Prescott||Eric Donnelly, MD||A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone (ANZGOG 0902/GOG-0274/RTOG 1174)|
|Adam Prescott||Eric Donnelly, MD||A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy (RTOG 1304)|
|Adam Prescott||Eric Donnelly, MD||Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy (RTOG 0724)|
|Adam Prescott||John Hayes, MD||Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed By Sorafenib In Hepatocellular Carcinoma (RTOG 1112)|
|Adam Prescott||John Hayes, MD||A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (RTOG 0848)|
|Adam Prescott||John Hayes, MD||Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma (NRG GI001)|
|Adam Prescott||John Kalapurakal, MD||Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (RTOG 0631)|
|Adam Prescott||Bharat Mittal, MD||Randomized Phase II And Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) (NRG HN001)|
|Adam Prescott||Bharat Mittal, MD||Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck (RTOG 1216)|